Cetuximab in combination with docetaxel in patients (pts) with metastatic castration resistant (mCRPC) and docetaxel-refractory prostate cancer: A multicenter phase II trial (SAKK 08/07)
Abstract only
Saved in:
Published in | Journal of clinical oncology Vol. 28; no. 15_suppl; p. 4666 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
20.05.2010
|
Online Access | Get full text |
Cover
Loading…
Summary: | Abstract only |
---|---|
ISSN: | 0732-183X 1527-7755 |
DOI: | 10.1200/jco.2010.28.15_suppl.4666 |